CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.225
-0.095 (-4.09%)
At close: Oct 26, 2026, 4:00 PM EDT
2.210
-0.015 (-0.67%)
Pre-market: Oct 27, 2026, 4:14 AM EDT
CytomX Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 | Buy | Maintains | $12 | +439.33% | Oct 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +439.33% | Sep 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $11 | Buy | Maintains | $11 | +394.38% | Aug 17, 2026 |
| Barclays | Barclays | Buy Maintains $16 | Buy | Maintains | $16 | +619.10% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +529.21% | Aug 7, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +394.38% | Jun 4, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $6 | Buy | Initiates | $6 | +169.66% | May 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $17 → $11 | Buy | Maintains | $17 → $11 | +394.38% | May 11, 2026 |